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Abstract
Background: Lyme neuroborreliosis (LNB) may present as meningitis, cranial neuropathy, acute
radiculoneuropathy or, rarely, as encephalomyelitis. We hypothesized that glia, upon exposure to
Borrelia burgdorferi, the Lyme disease agent, produce inflammatory mediators that promote the
acute cellular infiltration of early LNB. This inflammatory context could potentiate glial and
neuronal apoptosis.
Methods: We inoculated live B. burgdorferi into the cisterna magna of rhesus macaques and
examined the inflammatory changes induced in the central nervous system (CNS), and dorsal root
nerves and ganglia (DRG).
Results: ELISA of the cerebrospinal fluid (CSF) showed elevated IL-6, IL-8, CCL2, and CXCL13 as
early as one week post-inoculation, accompanied by primarily lymphocytic and monocytic
pleocytosis. In contrast, onset of the acquired immune response, evidenced by anti-B. burgdorferi
C6 serum antibodies, was first detectable after 3 weeks post-inoculation. CSF cell pellets and CNS
tissues were culture-positive for B. burgdorferi. Histopathology revealed signs of acute LNB: severe
multifocal leptomeningitis, radiculitis, and DRG inflammatory lesions. Immunofluorescence staining
and confocal microscopy detected B. burgdorferi antigen in the CNS and DRG. IL-6 was observed
in astrocytes and neurons in the spinal cord, and in neurons in the DRG of infected animals. CCL2
and CXCL13 were found in microglia as well as in endothelial cells, macrophages and T cells.
Importantly, the DRG of infected animals showed significant satellite cell and neuronal apoptosis.
Conclusion: Our results support the notion that innate responses of glia to B. burgdorferi initiate/
mediate the inflammation seen in acute LNB, and show that neuronal apoptosis occurs in this
context.
Published: 25 August 2009
Journal of Neuroinflammation 2009, 6:23 doi:10.1186/1742-2094-6-23
Received: 24 July 2009
Accepted: 25 August 2009
This article is available from: http://www.jneuroinflammation.com/content/6/1/23
© 2009 Ramesh et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Neuroinflammation 2009, 6:23 http://www.jneuroinflammation.com/content/6/1/23
Page 2 of 16
(page number not for citation purposes)
Background
Lyme neuroborreliosis (LNB) is caused by the spirochete
Borrelia burgdorferi. It manifests in 10–15% of untreated
Lyme disease patients [1]. LNB affects both the peripheral
and the central nervous systems (CNS), resulting in acute
and chronic inflammation accompanied with neurologi-
cal deficits that may persist for the lifetime of a patient [2].
Neuroborreliosis may present as meningitis, cranial neu-
ropathy, transverse myelitis, acute radiculoneuropathy or,
rarely, as encephalomyelitis [3]. Early symptoms after an
acute attack of LNB may include severe headaches,
chronic fatigue and flu-like symptoms, facial-nerve paral-
ysis, and motor dysfunction presenting as acute ataxia
with pain in the back and extremities of limbs, accompa-
nied by cognitive disorders and depression [4].
A sign of acute meningitis of both bacterial and viral ori-
gin is migration of large numbers of leukocytes into the
subarachnoid space, with such pleocytosis reaching values
of 100 to 1000 cells per μL [5]. Under normal conditions,
cerebrospinal fluid (CSF) contains 1–5 leukocytes per μL
[6]. In meningitis caused by bacteria such as Neisseria men-
ingitidis, Haemophilus influenza, or Streptococcus pneumo-
niae the local production of cytokines and chemokines by
glial and endothelial cells upon contact with pathogens is
currently regarded as the initial step in regulating the
directed migration of distinct leukocyte populations to an
inflammatory site within the CNS [7-10]. In Lyme menin-
gitis the cellular sources of these mediators are unknown.
The CSF of LNB patients shows abnormalities within 3 to
6 weeks after infection, manifested as mononuclear pleo-
cytosis, persistent plasma cells, intrathecal synthesis of B.
burgdorferi-specific immunoglobulins and presence of B.
burgdorferi  DNA [11]. Immune mediators such as
cytokines and chemokines implicated in playing a role in
the pathogenesis of various inflammatory diseases of the
nervous system have also been found in the CSF of LNB
patients [12-19]. Further, microscopic evaluation of
lesions from patients with LNB shows perivascular mono-
cytic and lymphocytic cell infiltration concomitant with
the presence of B. burgdorferi DNA [20,21].
Recently, we reported that the interaction of B. burgdorferi
with rhesus monkey brain parenchyma elicits the inflam-
matory mediators IL-6, IL-8, IL-1beta and CXCL13 from
glial cells, with concomitant oligodendrocyte and neuro-
nal apoptosis [22]. In addition, primary cultures of micro-
glia or astrocytes produced IL-6, TNF-alpha, IL-8, and the
macrophage inflammatory proteins CCL3 and CCL4 in
the presence of live B. burgdorferi [23]. Several of these
mediators are associated with LNB [24,25], play a major
role in the recruitment of leukocytes into the subarach-
noid space in various types of infectious meningitis [26],
and in the inflammatory response mounted by the CNS in
other neurodegenerative diseases such as multiple sclero-
sis and experimental autoimmune encephalomyelitis
[27,28]. We therefore reasoned that glial cells could be an
early source of the cytokines and chemokines detected in
the CSF during LNB. We further anticipated that this
inflammatory context could potentiate glial and neuronal
apoptosis, based on our earlier observations that docu-
mented that live B. burgdorferi induced inflammation and
oligodendrocyte and neuronal apoptosis in brain explants
ex vivo, and following intracerebral inoculation in vivo
[22].
To address our hypotheses we devised an in vivo model of
acute LNB in the rhesus monkey. Five rhesus macaques
were given intrathecal inoculations with live B. burgdorferi,
and 2 additional animals were given sham inoculations
and served as controls. CSF and serum samples were seri-
ally collected over a 6-week period from 2 of the infected
animals and one control, and over a 12-week period from
the other 3 animals and the other control. Relative con-
centrations of cytokines and chemokines were deter-
mined in CSF and serum by multiplex and sandwich
ELISA assays, to determine the immune mediators that
were specifically associated with the initiation of Lyme
meningitis along with the appearance of pleocytosis. CSF
cell pellets, and tissues from various regions of the brain
and spinal cord were cultured for spirochetes to evaluate
the presence of active infection. Levels of anti-C6 antibod-
ies [29] were determined in serial serum samples to mon-
itor the appearance of the acquired immune response
against  B. burgdorferi. Histopathological evaluation,
immunohistochemistry, immunofluorescence staining
and confocal microscopy of sections from the brain, spi-
nal cord, dorsal root ganglia (DRG) and heart tissues were
performed post-necropsy to detect the presence of inflam-
matory lesions, B. burgdorferi antigen, and to identify the
cells that produced immune mediators. We also looked
for glial and neuronal apoptosis in the parenchyma of the
brain and spinal cord, and in DRG by the in situ TUNEL
assay. The results of these evaluations are described
herein.
Methods
Spirochetal inoculum
B. burgdorferi strain B31 clone 5A19 spirochetes, passage
one, isolated from an ear biopsy of a previously infected
mouse, were grown in Barbour-Stoenner-Kelly (BSK)-H
medium supplemented with 6% rabbit serum and antibi-
otics (Rifampicin at 45.4 mg/ml, Phosphomycin at 193
mg/ml and Amphotericin at 0.25 mg/ml) (Sigma, St.
Louis, MO) to late logarithmic phase under microaer-
ophilic conditions. Spirochetes were pelleted at 2000 × g
for 30 min at RT. At the end of the run the rotor was left
to coast without breaking so as to minimize damage to the
live spirochetes. The culture was washed twice using phos-
phate buffered saline (PBS) pH 7.2 (Invitrogen, Grand
Island, NY) and resuspended in RPMI 1640 medium (Bio-Journal of Neuroinflammation 2009, 6:23 http://www.jneuroinflammation.com/content/6/1/23
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whittaker, Walkersville, MD) to contain a suspension of 1
× 108 spirochetes/ml.
Animals and intrathecal inoculation
Seven 3–7-year old male rhesus macaques (Macaca
mulatta) of Chinese origin were used in this study. The
inoculation protocol was approved by the Institutional
Animal Care and Use Committee of the Tulane National
Primate Research Center. Anesthetized animals received
up to 1 ml of RPMI 1640 medium with 1 × 108 spirochetes
(n = 5), or no spirochetes (n = 2) into the cisterna magna,
after removal of an equivalent volume of CSF. This dose
was found to be safe in studies involving intrathecal inoc-
ulation of Treponema pallidum, another spirochete, in rhe-
sus macaques [30]. Similar inoculum doses were used
previously in the rhesus monkey [31-34]. To monitor CNS
inflammation following inoculation, CSF (0.5–1.0 ml)
and serum (5 ml of blood) were collected on a weekly
basis for 4 weeks, and then once every two weeks until the
end of the study for each animal. Two inoculated animals
(DR50, EL81) and one control (EL66) were necropsied at
six weeks post-inoculation (PI) and three inoculated ani-
mals (DH50, EP51, CH82) and one control (EJ86) at 12
weeks PI. The procedure used for euthanasia was consist-
ent with the recommendations of the American Veterinary
Medical Association's Panel on Euthanasia.
CSF cell enumeration, and B. burgdorferi culture
CSF samples were maintained on ice after collection until
processed. Total cell numbers were determined using a
Reichert Bright-Line metalized hemocytometer (Thermo
Fisher Scientific, Waltham, MA) within 30 min of collec-
tion. For cytospin, preparations were made by centrifug-
ing the CSF at 300 × g at 4°C for 10 min. The cell pellet
was resuspended in 100 ml of fetal bovine serum, loaded
in a Shandon EZ cytofunnel set up on positively charged
slides, and spun at 700 rpm for 7 min with minimum
acceleration on a Shandon Cytospin centrifuge (Thermo
Fisher Scientific). Slides were air-dried and stained with
Wright stain (Fisher Scientific, Pittsburg, PA), mounted,
and stored at RT until evaluation. Slides were examined
for cellular composition and cell morphology. A 100–200
nucleated-cell differential count was performed from
multiple random areas of each slide under a 40 × objec-
tive. The CSF supernatant after removal of cells was col-
lected and spun down at 8000 × g at 4°C for 20 min. The
supernatant was aliquoted and frozen at -70°C for evalu-
ation of immune mediators. The pellet was resuspended
in 10 ml BSK-H medium, supplemented with 6% rabbit
serum and antibiotics as described above (Sigma) for cul-
ture of B. burgdorferi.
Detection of anti-VlsE (C6) antibodies in serum
Serum antibody levels to the VlsE C6 peptide (B. burgdor-
feri  B31) were quantified by ELISA using a procedure
described previously [29]. As is customary, the cut-off line
for positive ELISA values was set at the mean value of all
of the pre-immune serum specimens plus three times the
standard deviation of that mean. The probability that an
ELISA value above this cut-off line is negative is p = 0.003.
Quantification of immune mediators in CSF and serum
CSF and serum cytokines and chemokines were quanti-
fied with the Bio-Plex Human Cytokine 17-Plex Panel fol-
lowing the manufacturer's instructions (Bio-Rad,
Hercules, CA). The analytes detected by this panel are: Hu
IL-1beta, Hu IL-2, Hu IL-4, Hu IL-5, Hu IL-6, Hu IL-7, Hu
IL-8, Hu IL-10, Hu IL-12, Hu IL-13, Hu IL-17, Hu G-CSF,
Hu GMCSF, Hu IFN-gamma, Hu MCP-1/CCL2, Hu MIP-
1beta/CCL4, Hu TNF-alpha. The multiplex plate was read
using a Bio-Plex 200 Suspension Array Luminex System
(Bio-Rad). CXCL13 concentration was measured with a
sandwich ELISA (R&D, Minneapolis, MN). As with the
serology ELISA, the cut-off line for positive Bio-Plex and
sandwich ELISA values was set at the mean value for each
mediator of all of the pre-infection and control CSF spec-
imens plus three times the standard deviation of that
mean.
Collection of tissues for histopathological evaluation, 
detection of intracytoplasmic localization of immune 
mediators, and detection of B. burgdorferi by culture
Tissues were collected from various regions of the brain
and spinal cord and DRG, and fixed in formalin or Z-fixa-
tive (Anatech, Battle Creek, MI) for routine histopatholog-
ical evaluation. For the purpose of detecting
intracytoplasmic localization of cytokines, fresh unfixed
tissues were collected from various regions of the brain
and spinal cord, as well as DRG at necropsy, and immedi-
ately processed for blocking of intracytoplasmic cytokines
(modification of the method previously described [35],
by incubation of tissue slices for four hours in RPMI
medium (Invitrogen) containing 10% fetal bovine serum
(Invitrogen) and the fungal metabolite brefeldin A (Invit-
rogen), which blocks export of intracellular proteins via
the endoplasmic reticulum. Tissues were then fixed in 2%
paraformaldehyde in PBS pH 7.0 (USB, Cleveland OH),
and cryopreserved as described previously [35]. Tissue
samples from various regions of the brain and spinal cord
were also collected at necropsy in BSK-H medium, supple-
mented with 6% rabbit serum and antibiotics (Sigma) for
detection of B. burgdorferi by culture.
Immunofluorescence staining of intracytoplasmic immune 
mediators, phenotypic markers of producer cells and of 
cells in inflammatory lesions
For in situ analysis, the cryopreserved tissues were cryosec-
tioned into 16-μm sections as previously described [35].
Tissues collected in formalin or fixed with Z-fixative were
also sectioned into 10–15 μm sections, depending on theJournal of Neuroinflammation 2009, 6:23 http://www.jneuroinflammation.com/content/6/1/23
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availability of tissue. Presence of inflammatory lesions
was determined by routine histopathological evaluation
of tissues sectioned at 5 μm and stained with hematoxylin
and eosin (H&E). Immunohistochemical staining was
done using several monoclonal and polyclonal antibodies
(anti-CD3, CD20, and CD68, Table 1). All histological
sections were incubated with the primary antibody for 1
hour at room temperature, followed by biotinylated anti-
rabbit or anti-mouse secondary antibodies (Dako) as
appropriate for 30 minutes. Finally, sections were incu-
bated with avidin-biotin complex (ABC) (Vector labs,
Burlingame, CA) for 30 minutes, and the reaction was vis-
ualized with 3,3'-diaminobenzidine (Dako) as the chro-
mogen. Sections were subjected to immunofluorescence
staining as previously described [22]. The primary anti-
bodies against various immune mediators, cell pheno-
typic markers and B. burgdorferi are listed in Table 1.
Relevant isotype controls (Sigma) at the concentration of
the corresponding primary antibodies were also included.
Qualitative and quantitative assessment of glial and 
neuronal apoptosis
Glial and neuronal apoptosis was assessed by the in situ-
TUNEL assay in tissues collected from the brain and spinal
cord as well the DRG, that were directly fixed in 2% para-
formaldehyde at collection and cryopreserved and frozen
as previously described [22]. Sections were stained for any
one of the following brain cell markers: NeuN (neurons),
IBA-1 (microglia), GFAP-cy3 (astrocytes), or S-100 (astro-
cytes, oligodendrocytes, Schwann cells, satellite cells) by
incubation with the appropriate primary antibody (Table
1) followed by secondary antibodies conjugated with
Alexa Flour 568. Sections were fixed in 2% paraformalde-
hyde for 15 min, followed by a 15-min wash in PBS. Sec-
tions were then subjected to the terminal
deoxynucleotidyl transferase mediated UTP nick end labe-
ling (TUNEL)-ApopTagPlus fluorescein in situ apoptosis
assay (Chemicon, Temecula CA) as per the manufacturer's
instructions. Sections were also stained with anti-B. burg-
dorferi antibody as described above followed by secondary
antibody conjugated to Alexa Fluor 633. Contiguous sec-
tions stained with isotype controls at the respective con-
centrations of the primary antibody were included. To
confirm the identity of S-100-staining cells, S-100-stained
(Alexa Fluor 568) sections were also stained with anti-
GFAP followed by secondary antibody conjugated to
Alexa Fluor 633 (blue), before doing the TUNEL assay.
Cells that were only positive for S-100 (labeled red) were
regarded as oligodendrocytes in the CNS and Schwann
cells and/or satellite cells in the DRG [36], while those
that were labeled pink due to an overlap of S-100 (red)
and GFAP (blue) were considered to be astrocytes. Slides
were washed and mounted as described above and stored
at 4°C in the dark until viewed. The percentage of apop-
totic cells from ten fields were counted from each section
(more than 500 cells in all cases). The total number of
NeuN or S-100 positive cells respectively in each section
was ascertained, followed by the percentage of cells that
colocalized with the TUNEL signal for each cell marker,
All counts were made by viewing slides under a fixed mag-
nification of 63 × (corresponding to an area of 0.05 mm2)
using the confocal microscope (see below).
Confocal microscopy
Confocal microscopy was performed using a Leica TCS
SP2 confocal microscope (Leica Microsystems, Exton, PA)
as previously described [22]. Photoshop CS3 (Adobe sys-
tems Inc., San Jose, CA) was used for image processing.
Statistical analysis
The statistical significance of the apoptosis data was eval-
uated using the one-way ANOVA non-parametric analy-
sis, followed by the Tukey's stringency test using PRISM
software (IBM).
Results
Intrathecal inoculation with B. burgdorferi results in 
active, persistent CNS infection
Live B. burgdorferi spirochetes were recovered from the
CSF cell pellets of all but one of the inoculated animals at
various time points PI, as follows: animals DR50 and
EL81 at week 6, DH50 at week 2 and EP51 at week 10,
except for animal CH82, whose CSF cell-pellet cultures
yielded no spirochetes. Tissues harvested at necropsy from
the dura mater and the cervical spinal cord of one of the
two animals (EL81) that were inoculated with B. burgdor-
feri and euthanized 6 weeks PI were also culture positive
for B. burgdorferi. CSF cell-pellet or tissue cultures of the
control animals were negative throughout.
Early appearance of pleocytosis and inflammatory 
mediators in CSF
CSF pleocytosis was evident in all of the B. burgdorferi-
inoculated animals as early as one week PI; specimens
from the control animals were essentially free of cells
(Table 2). Pleocytosis was minimal in CH82, which
peaked to about 35 leukocytes/μl by week two PI. The
evaluation of the percentage of various leukocytes (differ-
ential counts) of cytospins prepared from the CSF samples
showed a predominance of lymphocytes and macro-
phage/monocytes. The differential counts of leukocytes in
the CSF of all of the animals with a pleocytosis > 50 cells/
μl is shown in Fig. 1.
CSF from infected animals showed levels above the cut-off
value for the cytokine IL-6 in animals DR50, EL81 and
DH50, between week 1–3 (Fig 2a). Animal EP51 showed
levels of IL-6 just exceeding the cut-off value at weeks 1
and 2 PI. The chemokine IL-8 was significantly elevated in
the CSF of all of the inoculated animals (Fig 2b), reachingJournal of Neuroinflammation 2009, 6:23 http://www.jneuroinflammation.com/content/6/1/23
Page 5 of 16
(page number not for citation purposes)
maximum levels ranging from 10.9 to 35 pg/ml between
weeks 1 and 2 PI. Monocyte chemoattractant protein-
1MCP-1/CCL2 was significantly elevated in all of the
infected animals (Fig 2c) except CH82, ranging between
350 pg/ml to 500 pg/ml by week 2 PI. The levels of IL-6 in
the CSF were higher than those observed in the serum of
all of the infected animals, except CH82, (Table 3), indi-
cating that this cytokine was produced primarily intrathe-
cally. On the other hand, IL-8 levels were much higher in
serum than they were in CSF (Table 3). The levels of CCL2
were considerably higher in the CSF compared to those
found at the corresponding time points in serum, suggest-
Table 1: Primary antibody and antibody/fluorochrome-conjugates against various immune mediators, B. burgdorferi, and cell 
phenotypes
MEDIATOR/CELL TYPE PRIMARY AB/SOURCE ISOTYPE DILUTION/CONCENTR.
IL-6 anti-human IL-6
(Abcam Inc. Cambridge, MA)
Rabbit IgG 1:1000
IL-8 anti-human IL-8
RDI Flanders, NJ
Rabbit IgG 10 μg/ml
CCL2 anti-human CCL2
(BD)
Mouse IgG1 10 μg/ml
anti-human CCL2
(Abcam)
Rabbit IgG 1:10
CXCL13 anti-human CXCL13
(R&D)
goat IgG 5 μg/ml
B. burgdorferi anti-whole cell preparation
(Accurate Chemicals, Westbury, NY)
Rabbit IgG 1:250
anti- B. burgdorferi-FITC
(Kirkegaard and Perry, Gaithersburg, MD)
Goat 1:10
Astrocyte anti-human GFAP-cy3
(Sigma St Louis, MO)
Mouse IgG1 1:200
anti-human GFAP
(Sigma)
Mouse IgG1 1:200
Astrocyte, Oligodendrocyte, Schwann cell, satellite cell anti-bovine S-100
(Sigma)
Rabbit IgG 1:1000
Microglia anti-Iba1 synthetic peptide
(Wako Pure Chemicals, Richmond, VA)
Rabbit IgG 1:100
Endothelial cells anti-human GLUT-1
(Chemicon)
Rabbit IgG 1:50
Neuron anti-mouse NeuN
(Chemicon)
Mouse IgG1 1:20
T cell anti-human CD3
(Dako, Carpinteria, CA)
Mouse IgG2a 1:10
B cell anti-human CD20
(Dako)
Mouse IgG1 1:200
Macrophage anti-human CD68
(Dako)
Mouse IgG1 1:50Journal of Neuroinflammation 2009, 6:23 http://www.jneuroinflammation.com/content/6/1/23
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ing, once again, a predominantly CNS origin for this
chemokine. The concentration of the B-lymphocyte
chemokine CXCL13/BLC was elevated above the cut-off
value in animals DR50, DH50, EL81, and EP51, reaching
peak values of around 5500 pg/ml between weeks 2 and 4
PI (Fig 2d). The CSF levels of CXCL13 were higher in three
out of four of the inoculated animals (DR50, EL81, and
DH50) as compared to those in paired serum specimens
(Table 3), implying a possible CNS origin for this media-
tor as well. The very early appearance of inflammatory
mediators (week 1–2 PI) in the CSF indicates that innate
immune responses are at play. In addition, the very high
serum concentrations of IL-8 detected as early as week 1
PI, much higher than the corresponding CSF levels, are
data to suggest that the infection became systemic soon
after the intrathecal inoculation.
Evaluation of the time of onset of the acquired immune 
response
The evaluation of the time of onset of acquired immunity
in the periphery was done by serially quantifying anti-VlsE
serum antibodies. VlsE, the antigenic variation lipopro-
tein of B. burgdorferi, is expressed by the spirochete unin-
terruptedly upon the initiation of infection in mammals.
We measured the anti-VlsE antibody response by quanti-
fying antibodies to the VlsE C6 peptide. The earliest that
this response was detected was by week 3 PI (animal
DR50), Fig. 3A. In all of the other animals that had
received a B. burgdorferi inoculation the anti-C6 response
appeared between weeks 4 and 6 PI, except for animal
CH82 (Fig. 3E), who did not have a detectable anti-C6
response. No anti-C6 response was detected in control
animals (Fig. 3F, 3G).
Histopathological evidence of Lyme meningitis, radiculitis, 
and inflammation in the DRG, along with evidence of B. 
burgdorferi antigen in both the CNS and peripheral 
nervous system (PNS) of infected animals
Histopathological evaluation of tissues collected from the
2 animals that were euthanized at 6 weeks PI revealed
severe multifocal lymphocytic, monocytic and plasma-
cytic leptomeningitis in the brain and spinal cord. Radicu-
litis was evidenced by inflammatory infiltrates in the
nerve roots of the cervical, thoracic, lumbar and sacral spi-
nal cord. Similar lesions were seen in animal DH50,
which was euthanized at 12 weeks PI. A representative
image of brain leptomeningitis is shown in Fig 4A. The
cellular infiltrates contained, in decreasing order of abun-
dance, B lymphocytes (CD20+), T lymphocytes (CD3+),
and monocyte/macrophages (CD68+). Figure 4B depicts a
confocal micrograph of a lesion found in the dura mater
of animal DR50 showing the presence of T cells, B cells
and monocyte/macrophages. Inflammatory infiltrates in
the vicinity of B. burgdorferi antigen were observed in the
dura mater (not shown) and frontal cortex of animals
DR50 (Fig. 4C), EL81 and DH50. As with the meninges,
the parenchymal cell infiltrates were composed chiefly by
B and T lymphocytes and few macrophages. B. burgdorferi
antigen was also present in tissues collected from the
periventricular areas and spinal cord of infected animals
(not shown). Radiculitis seen as inflammation of the dor-
sal roots collected from the cervical, thoracic, lumbar, and
sacral spinal cord was observed in animals DR50, EL81 (6-
week-long infection) and DH50 (12-week). A representa-
tive image of radiculitis is depicted in Fig. 4D. Inflamma-
tion and presence of B. burgdorferi antigen was also
observed in the DRG, in animals DR50 and DH50. A
Table 2: Cerebrospinal fluid pleocytosis
ANIMAL CEREBROSPINAL FLUID NUCLEATED CELL COUNT/μl
wk-0 wk-1 wk-2 wk-3 wk-4 wk-6 wk-8 wk-10 wk-12
DR50 1 371 119 540 66 72
EL81 0 133 62 22 19 9
EL66 302508
EP51 0 3 28 42 51 51 2 5 0 3
CH82 08 3 5 1 1 721 0 0
DH50 5 213 114 0 92 161 40 10 1
EJ86 003016 1 8 0 3
Total number of leukocytes/μl of CSF as a function of time PI, in animals DR50 and EL81 (up to 6 weeks PI) and EP51, CH82 and DH50 (up to 12 
weeks PI) and respective controls (EL66, EJ86).Journal of Neuroinflammation 2009, 6:23 http://www.jneuroinflammation.com/content/6/1/23
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chronic type of inflammation of DRG from animal DH50
is shown in Fig 4E. The presence of B. burgdorferi antigen
in the vicinity of CD3-labeling-T cells in the DRG is
shown in Fig. 4F. No inflammatory lesions were detected
at necropsy in the remaining animals that were given a B.
burgdorferi inoculation and were euthanized at 12-weeks
PI (EP51 and CH82), or in the control animals.
Glial cells and neurons are among the producers of 
inflammatory mediators
IL-6 was produced by both astrocytes and neurons, as vis-
ualized by intracytoplasmic staining of spinal cord tissues
from three of the five B. burgdorferi-inoculated animals
(DR50, EL81 and DH50). Fig. 5A shows IL-6 produced by
astrocytes in the spinal cord. IL-6 was also found in neu-
rons as well as extracellular in the DRG of animals DR50
and DH50 (Fig. 5B). CXCL13 and CCL2, two of the medi-
ators produced chiefly in the intrathecal compartment,
were localized to microglia in the spinal cord (Fig. 5C and
Fig. 5D respectively). CXCL13 was also detected in CD68-
labeled macrophages in the lesions (not shown). In addi-
tion, CCL2 and CXCL13 were present in endothelial cells,
especially in the periventricular areas of the brain (not
shown). IL-8 was not detectable in any of the tissues at the
time of necropsy.
IL-6, CCL2 and CXCL13 were undetectable in comparable
tissues from control animals (Fig. 5E, F, and 5G). No IL-6
was detected in astrocytes from the spinal cord or in neu-
rons from the DRG of a control animal (Fig 5E and 5F,
respectively). Similarly, microglia from the spinal cord of
control animals were devoid of mediators (IL-6, IL-8,
CCL2 or CXCL13). A representative image of microglia
lacking CCL2 is shown in Fig 5G. Non-specific signals
CSF pleocytosis is primarily lymphocytic and monocytic Figure 1
CSF pleocytosis is primarily lymphocytic and monocytic. Leukocyte differential count in CSF cytospin-smears showing 
the percentage of neutrophils, macrophages, lymphocytes, plasma cells and eosinophils found over time in animals with a pleo-
cytosis higher than 50 cells/μL (A. EL81, B. DR50, C. DH50, D. EP51).Journal of Neuroinflammation 2009, 6:23 http://www.jneuroinflammation.com/content/6/1/23
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were absent in contiguous sections that were stained with
immunoglobulin isotype controls at the concentrations of
the respective primary antibodies, followed by the corre-
sponding secondary antibodies.
Glial and neuronal apoptosis
All of the infected animals except CH82 showed signifi-
cant levels of both Schwann/satellite cell and neuronal
apoptosis in the DRG as compared to that seen in the
respective controls. The percentage of DRG Schwann/sat-
ellite cells (S-100+/GFAP-  staining cells) and neurons
undergoing apoptosis in each of the animals in the study,
as assessed by the in situ TUNEL assay is shown in Fig. 6A.
Schwann/satellite cells showed significant levels of apop-
tosis ranging from 4.35 ± 2.39% (p < 0.0001) to 10.35 ±
3.11% (p < 0.0001). Neuronal apoptosis was less preva-
lent and ranged from 3.83 ± 1.77% (p < 0.001) to 6.58 ±
1.99% (p < 0.0001). Higher levels of both Schwann/satel-
lite cell and neuronal apoptosis were observed in 2 of the
animals necropsied at 12 weeks PI (EP51 and DH50) as
compared to those necropsied at 6 weeks PI (Fig. 6A). A
qualitative view of the extent of the apoptosis around neu-
rons stained with antibody to NeuN observed in the DRG
is shown in Fig 6B. Fig. 6C shows the TUNEL signal
(green) seen in Schwann cells/satellite cells labeled with
antibody to S-100 followed by secondary antibody conju-
gated to Alexa fluor 568 (red) that are surrounding a neu-
ron that appears unstained as it does not take up S-100,
but is also showing the TUNEL signal in the center and
traces of B. burgdorferi antigen (blue) stained with anti-
body to whole B. burgdorferi followed by secondary anti-
body conjugated to Alexa fluor 633. Apoptotic DRG
neurons in the vicinity of B. burgdorferi antigen are shown
in Fig. 6D. No significant oligodendrocyte or neuronal
apoptosis was detected in the tissues collected from the
various regions of the brain and spinal cord. Apoptosis
was not detected in astrocytes or microglia in any of the
tissues.
Discussion
This study depicts an in vivo model of acute LNB in the
rhesus monkey. The model evidences the key features of
CSF pleocytosis, as well as the classical lesions of lep-
tomeningitis of brain and spinal cord and radiculitis that
have been reported in patients with early LNB [2,4,11-15].
Importantly, live spirochetes were detected by culture of
CSF cell pellets and CNS tissues collected post-mortem.
This finding provides evidence of active CNS infection in
this model.
Elevated CSF levels of both cytokines and chemokines
have been reported in Lyme meningitis patients. The
model not only reproduced these features but also pro-
vided, in addition, an insight into whether key inflamma-
tory mediators did originate within the CNS or in the
periphery, and an indication of the cellular sources of
these mediators. That glia, and thus innate immune proc-
esses, are at least in part the source of relevant cytokines
and chemokines was further suggested by the very early
appearance of pleocytosis, likely caused by the enhanced
concentration of these mediators in CSF within the first
week PI. Acquired immunity, measured as serum anti-
body to VlsE, was only evident by week 3 PI, and later
than week 3 in most animals. Perhaps the most significant
finding was that of neuronal and Schwann/satellite cell
apoptosis in DRG. As we discuss below, this phenomenon
Table 3: Peak CSF and corresponding serum values (pg/ml) of immune mediators in animals that were inoculated with B. burgdorferi.
MEDIATOR DR50 EL81 EP51 DH50 CH82
IL-6 (wk-1) (wk-1) (wk-1) (wk-1) (wk-1)
CSF 17.8 ± 0.4 10 ± 0.9 3.7 ± 0.5 46.9 ± 0.2 2.9 ± 0.7
SERUM 0.7 ± 0.2 0.3 ± 0.05 1 ± 0.2 0 3.9 ± 0.5
IL-8 (wk-1) (wk-2) (wk-2) (wk-1) (wk-2)
CSF 33.4 ± 4.2 15.7 ± 0.1 21.9 ± 1.0 34.5 ± 0.9 10.9 ± 2.0
SERUM 832.8 ± 75 697.6 ± 86.2 625.6 ± 3.7 3442 ± 149.2 422.4 ± 25
CCL2/MCP-1 (wk-2) (wk 2) (wk-3) (wk-3)
CSF 475.9 ± 25.2 345.6 ± 62.3 404.5 ± 6.8 442.3 ± 6.8 *
SERUM 114.1 ± 6.5 71.8 ± 0.4 106.2 ± 2.8 39 ± 11.2
CXCL13/BLC (wk-3) (wk-2) (wk-4) (wk-3)
CSF 5500 811.5 779 5317.8 ± 70.5 *
SERUM 300 748 1221 199
The time points at which peak values of various immune mediators (pg/ml) were observed in the CSF and corresponding values found in the serum 
of B. burgdorferi-infected animals are shown. Data represent the mean ± SD of duplicate determinations, except for CXCL13 in animals DR50, EL81, 
and EP51, where remaining CSF volume available only permitted a single determination.
* CSF concentrations of CCL2 and CXCL13 for animal CH82 were not significantly elevated with respect to control animals.Journal of Neuroinflammation 2009, 6:23 http://www.jneuroinflammation.com/content/6/1/23
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provides a probable etiology for Lyme neuroborreliosis of
the PNS.
The evidence of pleocytosis by weeks 1–2 PI in all of the
inoculated animals coincided with elevated levels of
immune mediators (Table 1, Fig 2). This correlation indi-
cates, but does not prove, that these immune mediators
had a role in mobilizing the immune cells from the
periphery into the CNS. The low levels of pleocytosis and
immune mediators in animal CH82, as well as the lack of
anti-C6 antibody response, could be due to an early clear-
ance of active infection in this animal.
The ability to culture spirochetes from CSF cell pellets and
CNS tissue and the occurrence of pleocytosis concomitant
with an increase of immune mediators in the CSF implies
that these phenomena occurred as a response to the pres-
ence of live spirochetes and spirochetal antigens in the
CNS. The influx of immune cells from the periphery into
the CNS is reflected in the cellular composition of the
inflammatory lesions that were identified in the brain,
spinal cord, dorsal root nerves and DRG of infected ani-
mals. The presence of B. burgdorferi antigen in CNS tissues
and DRG located in the vicinity of inflammatory lesions
indicates that the Lyme spirochete could have contributed
to the induction of the acute inflammatory response both
in the CNS as well as the PNS (DRG).
As chemokines are known to regulate inflammatory proc-
esses in the CNS in various bacterial and viral menin-
gitides [26], acute Lyme meningitis could also be initiated
via signaling mechanisms mediated by cytokines and
chemokines, produced by glial cells in response to the
Lyme spirochete. The presence of T cells and monocytes in
lesions and in the CSF of spirochete-inoculated animals in
this study, as well as those observed in the CSF of human
patients with LNB, could be a consequence of the chemo-
tactic action of the chemokine CCL2/MCP-1 [13,37,38];
Early appearance of cytokines and chemokines in the CSF Figure 2
Early appearance of cytokines and chemokines in the CSF. Levels of IL-6 (A), IL-8 (B), CCL2 (C) and CXCL13 (D) in 
the CSF of all of the animals in the study as a function of time PI. The dotted line represents the cut-off value obtained as 
described in Materials and Methods. Data represent the mean ± SD of duplicate determinations except for CXCL13, where 
availability of CSF only permitted duplicate determinations for all data points of animal DH50, and some data points of animals 
DR50 and CH82.Journal of Neuroinflammation 2009, 6:23 http://www.jneuroinflammation.com/content/6/1/23
Page 10 of 16
(page number not for citation purposes)
Emergence of the acquired immune response only after week 3 PI Figure 3
Emergence of the acquired immune response only after week 3 PI. C6 (VlsE) serum-antibody levels as a function of 
time PI, as measured by C6 ELISA in B. burgdorferi-infected animals. A. DR50, B. EL81, C. EL66, D. EP51, E. DH50, F. CH82, and 
G EJ86. The dotted line represents the cut-off value obtained as described in Materials and Methods. Data represents mean ± 
SD of triplicate determinations.Journal of Neuroinflammation 2009, 6:23 http://www.jneuroinflammation.com/content/6/1/23
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this chemokine is also involved in enhancing production
of inflammatory/immune cells from the bone marrow, an
important feature that can assist in recruitment of these
cells to the CNS. CCL2 was evident in the CNS as early as
week 2 PI, and was shown to be produced by microglia.
Moreover, its concentration in the CSF was up to 11 times
higher than it was in the serum, in paired specimens of
both fluids (Table 3); this is evidence to suggest that CCL2
was initially produced in the CSF. Considering that this
chemokine has other important functions in the CNS,
such as altering blood-brain barrier permeability [39],
and affecting the survival of neuronal cells in other
inflammatory neurodegenerative diseases such as multi-
ple sclerosis and Alzheimer's disease [21,23,28,40-44],
CCL2 could possibly be a contributor to the neurodegen-
eration [21,44] and vasculitis [3,44] observed in LNB.
The abundance of B cells in the lesions of spirochete-inoc-
ulated animals could be a consequence of the chemotactic
activity of the B lymphocyte chemoattractant CXCL13.
This chemokine was elevated in CSF by week 2 PI, and the
fact that its concentration in CSF was in most cases higher
than in paired serum specimens indicates, as with CCL2,
that CXCL13 was primarily produced in the CNS. Our
finding that microglia are among the cells that serve as a
source of CXCL13 in the CNS corroborates our previous
results that document the production of this chemokine
by microglia in rhesus monkey brain explants that were
exposed to B. burgdorferi [22]. It also echoes the observa-
tions of others who suggested a role for CXCL13 in LNB
[24,25], and entails a possible driving force for the
intrathecal B-cell infiltration and antibody production
commonly observed in patients with spirochetal diseases.
The neutrophil attractant IL-8, which was detected in the
CSF as early as week one PI, is likely a cause of the early
accumulation of neutrophils in the CSF. Interestingly,
even at this early time point, the concentration of IL-8 in
serum was up to 100 times higher than that in the CSF
(Table 3). No IL-8 was found in glial cells, in tissues col-
lected at necropsy, even though this cytokine is produced
in vitro both by astrocytes and microglia co-cultured with
B. burgdorferi [23].
IL-6, which was already elevated in CSF by week one PI,
could be contributed by glial cells, based on our observa-
tion of the localization of IL-6 to astrocytes, as well as to
neurons. IL-6 has been documented to play a role in
mediating inflammation in various inflammatory dis-
eases of the nervous system [45-48] and in the pathogen-
esis of LNB [49,50]. Our observations affirm our previous
report documenting astrocyte-derived IL-6 in response to
live B. burgdorferi [22]. We have also previously shown
that live B. burgdorferi as well as purified lipoproteins from
Histopathological evaluation and immunofluorescence stain- ing of lesions in the brain, dorsal root nerves and DRG Figure 4
Histopathological evaluation and immunofluores-
cence staining of lesions in the brain, dorsal root 
nerves and DRG. A) Composite light microscope image of 
leptomeningitis in the brain of a B. burgdorferi-inoculated ani-
mal (DR50) showing lymphocytic, plasmacytic and monocytic 
infiltration by hematoxylin and eosin staining, as well as 
immunohistochemical staining showing CD3-labeled T cells, 
CD-20-labeled B cells, and CD68-labeled macrophages. B) 
Confocal micrograph showing immunofluorescence staining 
of CD3-labeled T cells (green), CD20-labeled B cells (blue) as 
well as CD68-labeling macrophages (red) in a representative 
inflammatory lesion from the meninges of animal DR50. C) 
FITC-labeled B. burgdorferi antigen (green) in the vicinity of 
CD3-staining T cells (red) and CD68-staining macrophages in 
lesions found in the frontal cortex of animal DR50. D) 
Radiculitis in the dorsal root of a cervical spinal nerve proxi-
mal to the ganglion of animal DH50. There is abundant lym-
phocytic, and monocytic infiltration as well as plasma cells. A 
few adjacent nerve fibers have swollen sheaths. E) Chronic-
type inflammation of DRG from animal DH50 showing infil-
trates of lymphocytes, plasma cells, and monocytes. F) B. 
burgdorferi antigen stained with antibody to B. burgdorferi 
labeled with FITC, in the vicinity of the CD3-staining T cells 
(red) in lesions found in DRG of animal DR50.Journal of Neuroinflammation 2009, 6:23 http://www.jneuroinflammation.com/content/6/1/23
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Visualization of immune mediators and their producer cells in the CNS of B. burgdorferi-infected animals Figure 5
Visualization of immune mediators and their producer cells in the CNS of B. burgdorferi-infected animals. A) 
Indication of the cytokine IL-6 (green) due to staining with anti-IL-6 antibody followed by secondary antibody conjugated with 
Alexa fluor 488, in astrocytes (red), due to staining with anti-GFAP-cy3 in the spinal cord of animal DH50. The yellow signal is 
due to co-localization of the astrocytic marker GFAP (red) and IL-6 (green) within the astrocytes. B) The cellular localization of 
IL-6 (green) in neurons appearing red due to staining with anti-NeuN antibody, followed by secondary antibody conjugated 
with Alexa fluor 568. As NeuN is a nuclear antigen it is seen to stain the neuronal nucleus, while IL-6 is evident in the cyto-
plasm and extracellularly. C) The presence of CXCL13 (green) due to staining with anti-CXCL13 antibody followed by second-
ary antibody conjugated with Alexa fluor 488, in microglia (red) due to staining with anti-IBA-1 followed by secondary antibody 
conjugated to Alexa fluor 568 in the spinal cord of animal DH50. Intracytoplasmic staining of CXCL13 in microglia appears yel-
low. D) Evidence of CCL2 (green) due to staining with anti-CCL2 antibody followed by secondary antibody conjugated with 
Alexa fluor 488, in microglia (red) in the spinal cord of DH50. E). A representative image of the absence of IL-6 (which should 
have appeared green due to labeling with anti-IL-6 antibody followed by secondary antibody conjugated to Alexa fluor 488) in 
astrocytes labeled with anti-GFAP-cy3 (red) in the spinal cord of a control animal. F). Absence of IL-6 in neurons appearing red 
due to staining with anti-NeuN antibody, followed by secondary antibody conjugated with Alexa fluor 568 in the DRG of a 
control animal. G). Absence of CCL2 in microglia (red) due to staining with anti-IBA-1 followed by secondary antibody conju-
gated to Alexa fluor 568 in the spinal cord of control animals. The unstained tissue in all images appears gray due to differential 
interference contrast (DIC) imaging.Journal of Neuroinflammation 2009, 6:23 http://www.jneuroinflammation.com/content/6/1/23
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Schwann cell and/or Satellite cell and neuronal apoptosis in DRG Figure 6
Schwann cell and/or Satellite cell and neuronal apoptosis in DRG. A) Percentage of Schwann/satellite cells and neu-
rons dying by apoptosis as revealed by the in situ TUNEL assay performed on tissues from the DRG of all of the animals in the 
study. Data represent the mean values ± SD of the counts from ten fields. The p values represent the statistical significance 
with respect to the control animal (EL66 wk 6 and EJ86 wk 12) for each group. B) A qualitative view of the extent of the apop-
tosis (green) around neurons stained with antibody to NeuN followed by secondary antibody conjugated to Alexa fluor 568 
(red) observed in the DRG of DH50 following the in situ TUNEL assay and immunofluorescence staining and confocal micros-
copy. C) Apoptosis of DRG Schwann/satellite cells. DRG sections from animal DH50 were labeled with antibody to S-100, fol-
lowed by secondary antibody conjugated to Alexa fluor 568 (red). Cells undergoing apoptosis, stained using the TUNEL assay, 
are shown in green (FITC). Apoptotic Schwann/satellite cells surround a neuron that appears unstained as it does not take up 
the S-100 antibody, but is also showing the TUNEL signal in the center. D) Neurons stained with anti-NeuN antibody (red), 
and undergoing apoptosis (green) are shown in the vicinity of residual B. burgdorferi antigen (blue). The confocal micrograph is 
from a DRG section of animal DH50, following application of the in situ TUNEL assay and immunofluorescence staining. B. burg-
dorferi antigen is seen as blue due to labeling with anti-whole-cell B. burgdorferi antigen followed by secondary antibody conju-
gated to Alexa 633.Journal of Neuroinflammation 2009, 6:23 http://www.jneuroinflammation.com/content/6/1/23
Page 14 of 16
(page number not for citation purposes)
this spirochete are able to induce the production of IL-6 in
primary cultures of rhesus glial cells [23,51].
The role of microglia in initiating or promoting inflam-
matory processes in the CNS by facilitating the recruit-
ment of peripheral immune cells has been well
documented [52-54]. Here, we show that microglia can
contribute the chemokines CCL2 and CXCL13 in the CNS
and that the innate immune response mounted against
the Lyme spirochete in the CNS, as evidenced by the
appearance of immune mediators in the CSF, occurs
before the onset of the acquired immune response. The
latter was measured by the appearance of anti-C6 (VlsE)
serum antibody. The induction of a syndrome indistin-
guishable from acute LNB prior to the onset of specific
acquired immunity indicates that this syndrome can be
induced by innate immune mechanisms, thus providing
an insight into the pathogenesis of the acute form of the
disease.
An important finding of this study is the significant
Schwann/satellite cell and neuronal apoptosis in the DRG
of B. burgdorferi-infected animals. This finding corrobo-
rates previous observations made in an ex vivo model of
the interaction of live B. burgdorferi with brain explants
from the frontal cortex of rhesus brain [22]. Our failure to
find significant apoptosis in the brain and spinal cord in
the in vivo model may be due to limited interaction of B.
burgdorferi  with parenchymal tissue, compounded with
clearance of apoptotic cells by phagocytes such as macro-
phages and microglia [55]. In contrast, the detection of
apoptotic cells in the DRG could be brought about by a
delay in the recruitment of phagocytic cells to this area or
by the presence of a larger concentration of neurons and
Schwann/satellite cells per unit volume in the DRG as
compared to neurons and oligodendrocytes in the paren-
chyma.
Mechanisms of neuronal damage as a consequence of bac-
terial meningitis have been studied extensively [56,57].
Neural injury has been documented in experimental neo-
natal meningitis due to group B streptococci [58]. The
neurological sequelae of meningitis caused by Streptococ-
cus pneumoniae also include neuronal dysfunction due to
neuronal apoptosis [59]. Similar mechanisms of neuronal
damage and neuronal dysfunction could be contributing
to the cognitive and memory impairment seen in patients
with LNB.
Neuroinflammation during bacterial meningitis is known
to affect both neuronal synaptic plasticity as well as neu-
ronal survival. Death of Schwann/satellite cells could also
result in impaired neuronal function [60,61]. As we have
shown that Lyme meningitis sets the stage for neuroin-
flammation and Schwann/satellite cell and neuronal
damage, immune-mediated glial and neuronal damage
could be among the underlying mechanisms of the cogni-
tive and memory loss seen in LNB patients. The axonal
damage observed in the PNS in LNB patients as well as in
the rhesus monkey model of Lyme disease [62,63] could
be a result of immune mediated death of DRG neurons,
resulting in impaired nerve function.
Another potentially relevant finding of this study is the
presence of IL-6 in neurons of DRG in infected animals.
The induction of IL-6 in neurons of adult rat DRG that are
adjacent to injured peripheral nerves has been shown to
be a specific response to nerve injury [64,65]. IL-6 is sug-
gested to play a critical role in affecting the activity of neu-
rons in the DRG, increasing the receptiveness of neurons
at nerve endings, axons as well as nerve cell bodies, result-
ing in lower back pain and sciatica [66]. IL-6-mediated
signaling in glial cells in the spinal cord after spinal nerve
injury is also known to play a role in the transduction of
pain [67]. Thus the cytokine IL-6 produced in neuronal
cells in the DRG as well as in glial and neuronal cells in
the spinal cord that we observed in this model could be a
possible factor contributing to the transduction of the
lumbar pain that is often observed in patients with LNB.
Conclusion
In conclusion, the findings of this study emphasize that
glial cells are among the sources of a distinct set of
immune mediators particularly the cytokines IL-6, and the
chemokines CCL2 and CXCL13, in response to the Lyme
spirochete in the CNS. Importantly, the observation of
Schwann cell and/or satellite cell and neuronal apoptosis
in the DRG as well as the inflammatory cytokine IL-6 in
neurons in this region lend support to our hypothesis that
the direct interaction of the spirochete with neural cells, a
phenomenon that had long been predicted by experi-
ments performed in vitro [68,69], and the ensuing
immune response, may result in neurological damage.
Our results are consistent with the notion that innate
immune responses of glial cells to the Lyme disease spiro-
chete initiate and/or mediate the inflammation that char-
acterizes acute Lyme meningitis, and provide evidence of
concomitant apoptotic cell death in the DRG. The latter
could be the early event that leads to peripheral neuropa-
thy in LNB.
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